Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Beasley, B. Lanier, Z. Márk, A. Moton, H.J. Kim, B. Hederer (Wellington, New Zealand; Fort Worth, East Hanover, United States Of America; Törökbálint, Hungary; Basel, Switzerland). Long-term efficacy of QMF149 in persistent asthma. Eur Respir J 2012; 40: Suppl. 56, 1791

Member's Comments

No comment yet.

Related content which might interest you: Evaluating the efficacy of omalizumab in severe persistent asthma patients Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Efficacy of the long-term therapy with simbicort in children with bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 395s Year: 2005 Long-term efficacy of 1 year anti-inflammatory treatment in paediatric patients with mild persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 379s Year: 2004 Long-term effectiveness of PEF-guided self-management in asthma Source: Annual Congress 2007 - Novel issues in the treatment and control of asthma Year: 2007 Long-term treatment of aspirin-intolerante asthma with budesonide. Effectivity and safety Source: Eur Respir J 2001; 18: Suppl. 33, 156s Year: 2001 Comparable efficacy of calcilytic and corticosteroid in short-term and long-term allergic asthma models in vivo Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Immunological effectiveness of atorvastatin in complex therapy of severe persistent bronchial asthma Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Early treatment response may predict long-term mepolizumab benefit in severe asthma Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 Long-term safety and efficacy of budesonide/formoterol in Japanese patients with asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 The efficacy of omalizumab in severe in asthma after treatment withdrawal Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Long-term benefits of pulmonary rehabilitation in patients with chronic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 454s Year: 2002 Assesment of long-term omalizumab treatment in severe allergic asthma Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012 Efficacy and safety of long-term therapy with Salamol combined with Beclason versus Salamol only in patients with mild persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 42s Year: 2002 Real-life long-term omalizumab therapy in children with severe allergic asthma Source: Eur Respir J 2015; 46: 856-859 Year: 2015 Immunological effectiveness of N-acetylcystein in complex therapy in severe persistent bronchial asthma patients Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Long-term safety of inhaled formoterol in adult asthma patients Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Long-term effectiveness of a staged assessment for paediatric problematic severe asthma Source: Eur Respir J 2012; 40: 264-267 Year: 2012 Efficacy of ruzam in the treatment of patients with mild-to-moderate asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004